Chief Executive Officer
In times of crisis, it is good to have a partner like Oost NL. Where possible they show financial leniency and they bring proactive other support options to our attention.
After celebrating Bloodless Medicine and Surgery Day on May 16, HemoClear is attending the Annual Bloodless Medicine and Surgery Week Conference. On Thursd
78% mortality reduction in ICU-admitted COVID-19 patients in Suriname after treatment with convalescent plasma (CP) obtained by the HemoClear blood filter.
HemoClear B.V. received CE Mark approval for its first-in-class, technology, the HemoClearTM autologous blood filter